Outcomes of Pregnant Individuals With Epilepsy
Obstetrical & Neurological Outcomes in Individuals With Epilepsy During Pregnancy
This study looks at how following epilepsy care guidelines during pregnancy affects the health of both mothers with epilepsy and their newborns.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Sex | Female |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT05485649 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the pregnancy, delivery, neonatal, and epilepsy outcomes in individuals with epilepsy who are pregnant. It will follow participants at the Maternal and Infant Health Programs at the University Health Network and the Toronto Western Hospital Epilepsy Clinic. The study focuses on the association between adherence to recommended epilepsy management guidelines during pregnancy and the resulting health outcomes for both the mother and the newborn.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant individuals diagnosed with epilepsy who have been seen at the Toronto Western Hospital Epilepsy Clinic since June 1, 2022.
Not a fit: Patients who are not pregnant or those who do not have a diagnosis of epilepsy may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into optimizing care for pregnant individuals with epilepsy, potentially improving maternal and neonatal health outcomes.
How similar studies have performed: Other studies have explored the outcomes of epilepsy in pregnancy, suggesting that this area of research is relevant and may yield significant findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. WWE seen at the Toronto Western Hospital Epilepsy Clinic since June 1st 2022. 2. Pregnant at any point between June 1st 2022 and June 1st 2024 (period of enrolment). 3. Diagnosed with epilepsy as per the International League Against Epilepsy (ILAE) 2014 definition of epilepsy. Exclusion Criteria: * None
Where this trial is running
Toronto, Ontario
- University Health Network — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Study coordinator: Esther Bui, MD
- Email: Esther.Bui@uhn.ca
- Phone: 416-603-5320
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.